Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Cerebrovascular event (all doses) · postmenopausal women with or without vasomotor symptoms

It is very uncertain whether tibolone changes cerebrovascular event (all doses) compared with combined HT (very low certainty).

1 finding from 1 review

Short‐term and long‐term effects of tibolone in postmenopausal women 2016 · Cochrane Headline outcomes only
OR 0.76 [0.16, 3.66]
4 studies · 4562 participants
Very low

Cerebrovascular event (all doses) · postmenopausal women with or without vasomotor symptoms

It is very uncertain whether tibolone changes cerebrovascular events (all doses) compared with placebo (very low certainty).

1 finding from 1 review

Short‐term and long‐term effects of tibolone in postmenopausal women 2016 · Cochrane Headline outcomes only
OR 1.74 [0.99, 3.04]
4 studies · 7930 participants
Very low